全文获取类型
收费全文 | 157984篇 |
免费 | 9613篇 |
国内免费 | 835篇 |
专业分类
耳鼻咽喉 | 1782篇 |
儿科学 | 5017篇 |
妇产科学 | 3785篇 |
基础医学 | 21838篇 |
口腔科学 | 2724篇 |
临床医学 | 14683篇 |
内科学 | 35687篇 |
皮肤病学 | 3361篇 |
神经病学 | 14414篇 |
特种医学 | 4974篇 |
外国民族医学 | 48篇 |
外科学 | 18847篇 |
综合类 | 2026篇 |
现状与发展 | 1篇 |
一般理论 | 57篇 |
预防医学 | 14540篇 |
眼科学 | 2803篇 |
药学 | 10641篇 |
6篇 | |
中国医学 | 914篇 |
肿瘤学 | 10284篇 |
出版年
2023年 | 976篇 |
2022年 | 1752篇 |
2021年 | 4229篇 |
2020年 | 2401篇 |
2019年 | 3743篇 |
2018年 | 6111篇 |
2017年 | 4027篇 |
2016年 | 3490篇 |
2015年 | 3836篇 |
2014年 | 5093篇 |
2013年 | 7208篇 |
2012年 | 10696篇 |
2011年 | 10820篇 |
2010年 | 6086篇 |
2009年 | 5213篇 |
2008年 | 8871篇 |
2007年 | 9200篇 |
2006年 | 8822篇 |
2005年 | 8651篇 |
2004年 | 7977篇 |
2003年 | 7464篇 |
2002年 | 7119篇 |
2001年 | 3672篇 |
2000年 | 3737篇 |
1999年 | 3206篇 |
1998年 | 1331篇 |
1997年 | 1045篇 |
1996年 | 931篇 |
1995年 | 798篇 |
1994年 | 701篇 |
1993年 | 670篇 |
1992年 | 1684篇 |
1991年 | 1499篇 |
1990年 | 1444篇 |
1989年 | 1322篇 |
1988年 | 1253篇 |
1987年 | 1173篇 |
1986年 | 1084篇 |
1985年 | 992篇 |
1984年 | 740篇 |
1983年 | 587篇 |
1982年 | 390篇 |
1979年 | 559篇 |
1978年 | 380篇 |
1977年 | 355篇 |
1976年 | 331篇 |
1974年 | 393篇 |
1973年 | 366篇 |
1972年 | 381篇 |
1971年 | 326篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
目的 研究模拟舰船两种剂量水平磁场复合噪声、高温对机体联合作用的特点。方法 采用有交互作用的三因素二水平的正交试验设计方法及方差分析法,按正交表L8(2^7)的要求安排8种复合暴露剂量组合,分别将兔和大鼠分为8个复合暴露组和8个对照组。结果 兔球结膜毛细血管管径、大鼠肝和脾脏HSP70的分析结果显示出磁场是对其影响的主因素(均为P〈0.01),其次是高温(均为P〈0.05),大鼠下丘脑AVP和大鼠脑组织HSP70的分析结果显示出磁场是对其影响的主因素(均为P〈0.05)。兔血浆内皮素的分析结果显示出磁场与噪声交互作用所对应的F值有非常显著性意义(P〈0.01),磁场与噪声、高温三者之间交互作用所对应的F值也有显著性意义(P〈0.05)。结论 磁场是对上述指标影响的主因素,而高温也是重要因素;磁场与噪声有交互作用,磁场与噪声、高温三者之间也有交互作用;应该重视舰船环境因素对舰船人员的复合作用。 相似文献
74.
Deng H. Le W. - D. Hunter C. B. 《世界核心医学期刊文摘》2006,2(6):17-18
背景:Parkin基因(PRKN)突变可导致常染色体隐性遗传性早发帕金森病(EOPD)。目的:探讨EOPD白人家族PRKN突变的表现和基因型-表型关系。设计:对EOPD家族的3代20例成员进行基因分析,该家族有4例患者。应用直接基因组DNA测序、半定量聚合酶链反应、实时定量聚合酶链反应以及逆转录酶聚合酶链反应分析以确定PRKN突变。结果:4例早发患者(年龄30—38岁)被确定有PRKN复合杂合突变(T240M和EX5_6缺失),虽然PRKN的杂合T240M和纯合EX5_6缺失突变已有描述,但是据悉,本文为上述复合杂合突变的首次报道。患者的表型为典型常染色体隐性遗传性EOPD的表现,其特征是对左旋多巴治疗有效、相对缓慢的进展和运动障碍。所有杂合突变的基因携带者(T240M或EX5_6缺失)和1例56岁的复合杂合突变女性携带者(T240M和EX5_6缺失)无任何神经系统症状。结论:研究发现,PRKN基因复合杂合突变(T240M和EX5_6缺失)导致一个大的白人家族中4例成员发生常染色体隐性遗传性EOPD。另外1例成员具有相同的突变,比4例患者的平均发病年龄大10岁,并且无本病的临床表现。不完全的外显率对遗传咨询具有暗示作用,并且提示复杂的基因一环境交互作用在PRKN相关EOPD的发病机制中发挥作用。 相似文献
75.
Dino Donataccio Francine Roggen Chantal De Reyck Catherine Verbaandert Monique Bodeus Jan Lerut 《Transplant international》2006,19(1):38-43
The use of livers from anti-hepatitis B core (HBc) positive donors can alleviate donor shortage. Nineteen of 367 (6%) adults receiving anti-HBc positive allografts [three were hepatitis B antigen (HBsAg) negative, hepatitis B antibody (HBsAb) positive; four were HBsAg positive and 12 were not exposed to hepatitis B viral (HBV) infection] were retrospectively reviewed. In HBsAg negative recipients, immunoprophylaxis (IP) was guided by viral serology and immunohistochemistry (IH) of day 0 and day 7 liver biopsies. If IH was negative, IP was stopped. None of three HBsAg negative, HBsAb positive recipients infected; one (replicating) of four HBsAg positive recipients reinfected and seven of eight (87.5%) HBsAg, HBsAb negative recipients, who did not receive long-term IP, infected after a median time of 2 years (range 1-5); one patient died of liver failure. Four HBsAg, HBsAb negative recipients, receiving life-long IP, remained infection free. Anti-HBc positive donor livers must be directed selectively first to HBsAg positive recipients, next to recipients having HBV antibodies and finally to HBV-naive recipients. Identification of both donor and recipient risk factors for HBV infection before transplantation allows indiscriminate use of antiviral prophylaxis. The necessity for IP therapy should be guided by HBV-DNA testing of donor liver tissue and serum. IH of early liver biopsies is an unreliable marker for predicting antiviral treatment requirements. 相似文献
76.
I García-Rubio C Martínez-Cócera T Robledo Echarren S Vázquez Cortés 《Journal of investigational allergology & clinical immunology》2006,16(4):264-265
Eye drops contain several ophthalmic medications which can produce allergic reactions. We report the case of a patient with contact dermatitis from neomycin and a probable fixed exanthema after parenteral administration of tobramycin who tolerated topical tobramycin and other aminoglycosides. 相似文献
77.
Alexander Stoff MD ; Angel A. Rivera PhD ; N. S. Banerjee PhD ; J. Michael Mathis PhD ; Antonio Espinosa-de-los-Monteros MD ; Long P. Le PhD ; Jorge I. De la Torre MD ; Luis O. Vasconez MD ; Thomas R. Broker PhD ; Dirk F. Richter MD ; Mariam A. Stoff-Khalili MD ; David T. Curiel MD PhD 《Wound repair and regeneration》2006,14(5):608-617
Genetically modified keratinocytes and fibroblasts are suitable for delivery of therapeutic genes capable of modifying the wound healing process. However, efficient gene delivery is a prerequisite for successful gene therapy of wounds. Whereas adenoviral vectors (Ads) exhibit superior levels of in vivo gene transfer, their transductional efficiency to cells resident within wounds may nonetheless be suboptimal, due to deficiency of the primary adenovirus receptor, coxsackie-adenovirus receptor (CAR). We explored CAR-independent transduction to fibroblasts and keratinocytes using a panel of CAR-independent fiber-modified Ads to determine enhancement of infectivity. These fiber-modified adenoviral vectors included Ad 3 knob (Ad5/3), canine Ad serotype 2 knob (Ad5CAV-2), RGD (Ad5.RGD), polylysine (Ad5.pK7), or both RGD and polylysine (Ad5.RGD.pK7). To evaluate whether transduction efficiencies of the fiber-modified adenoviral vectors correlated with the expression of their putative receptors on keratinocytes and fibroblasts, we analyzed the mRNA levels of CAR, alpha upsilon integrin, syndecan-1, and glypican-1 using quantitative polymerase chain reaction. Analysis of luciferase and green fluorescent protein transgene expression showed superior transduction efficiency of Ad5.pK7 in keratinocytes and Ad5.RGD.pK7 in fibroblasts. mRNA expression of alpha upsilon integrin, syndecan-1 and glypican-1 was significantly higher in primary fibroblasts than CAR. In keratinocytes, syndecan-1 expression was significantly higher than all the other receptors tested. Significant infectivity enhancement was achieved in keratinocytes and fibroblasts using fiber-modified adenoviral vectors. These strategies to enhance infectivity may help to achieve higher clinical efficacy of wound gene therapy. 相似文献
78.
79.
Victor Aboyans Louis Labrousse Philippe Lacroix Jér?me Guilloux Seifeddine Sekkal Alexandre Le Guyader Elisabeth Cornu Marc Laskar 《European journal of cardio-thoracic surgery》2006,30(2):300-304
BACKGROUND: Despite major improvement in surgical techniques and intensive care management, stroke remains one of the most devastating complications of coronary artery bypass grafting (CABG). We aimed to determine factors predicting the occurrence of stroke during CABG. A special interest was focused on preoperative therapies. METHODS: We prospectively enrolled 810 consecutive candidates for CABG alone in a specific database, including all pre- and perioperative data (history, clinical, therapeutic, cardiac catheterization, surgical and intensive care data). Univariate tests and then multiple logistic regression analysis were used to determine independent predictive factors. RESULTS: During the first postoperative month, stroke occurred in 11 cases and transient ischemic attack (TIA) in 4 additive cases (cumulative rate: 1.85%). After the multivariate analysis, the following factors remained significant (p<0.05) in the predictive model, with corresponding odds ratios between brackets: redo cardiac surgery (7.45), unstable cardiac status (4.74), past history of cerebrovascular disease (4.14), past history of peripheral arterial disease (3.55), whereas the presence of preoperative statins was protective (0.24, 95% IC: 0.07-0.78). The addition of perioperative data (aortic calcification, postoperative arrhythmia, on/off-pump surgery) did not change the final predictive model. CONCLUSION: To our knowledge, this is the first real-world observational report highlighting the interest of statins for the prevention of stroke in the very special situation of CABG. Even though according to randomized trials coronary patients have a benefit from these drugs, a special level of interest should be directed towards those presenting the above-mentioned risk factors. 相似文献
80.